Brain Biomarkers for Assessment of Brain Damage

The course provides an in-depth examination of innovative methodologies for the serological assessment of brain damage, focusing on various conditions such as ischemic strokes, traumatic brain injuries (ranging from concussions to coma), and incomplete spinal cord injuries. These assessments utilize neurotoxicity biomarkers, specifically the ionotropic glutamate receptors family, which play a critical role in the pathophysiology of these conditions.

Comprehensive research and clinical data are presented, highlighting the correlation between biomarker levels and clinical outcomes. This includes integrating findings from cognitive and clinical observations with advanced imaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI). The course aims to equip participants with a thorough understanding of the diagnostic and prognostic value of these biomarkers.

Additionally, the course outlines a practical roadmap for the medical application of brain-borne biomarkers. This includes their potential use in early diagnosis, monitoring disease progression, and evaluating therapeutic responses. By combining theoretical knowledge with clinical practice, the course seeks to enhance participants' ability to apply these biomarkers effectively in various medical settings, ultimately improving patient outcomes in neurological conditions.